These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3895947)

  • 1. Moxalactam versus clindamycin plus tobramycin in the treatment of obstetric and gynecologic infections.
    Sweet RL; Ohm-Smith M; Landers DV; Robbie MO
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):808-17. PubMed ID: 3895947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Moxalactam vs tobramycin-clindamycin. A randomized trial in secondary peritonitis.
    Stellato TA; Danziger LH; Hau T; Gauderer MW; Ferron JL; Gordon N
    Arch Surg; 1988 Jun; 123(6):714-7. PubMed ID: 3285809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of moxalactam versus clindamycin/tobramycin in the treatment of mixed anaerobic/aerobic infections.
    Joshi M; Fitzpatrick BJ; Warren JW; Caplan ES; Tenney JH
    Am Surg; 1986 Sep; 52(9):467-71. PubMed ID: 3530075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ampicillin/sulbactam versus metronidazole-gentamicin in the treatment of soft tissue pelvic infections.
    Crombleholme WR; Ohm-Smith M; Robbie MO; DeKay V; Sweet RL
    Am J Obstet Gynecol; 1987 Feb; 156(2):507-12. PubMed ID: 3030109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moxalactam versus clindamycin plus tobramycin for the treatment of puerperal infections.
    Pastorek JG; Faro S; Aldridge KE; Nicaud SK
    South Med J; 1987 Sep; 80(9):1116-9. PubMed ID: 3306943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefoxitin plus tobramycin and clindamycin plus tobramycin. A prospective randomized comparison in the therapy of mixed aerobic/anaerobic infections.
    Nicolle LE; Harding GK; Louie TJ; Thomson MJ; Blanchard RJ
    Arch Surg; 1986 Aug; 121(8):891-6. PubMed ID: 3524511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous metronidazole or clindamycin with tobramycin for therapy of pelvic infections.
    Gall SA; Kohan AP; Ayers OM; Hughes CE; Addison WA; Hill GB
    Obstet Gynecol; 1981 Jan; 57(1):51-8. PubMed ID: 7005778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections.
    Tally FP; Kellum JM; Ho JL; O'Donnell TF; Barza M; Gorbach SL
    Antimicrob Agents Chemother; 1986 Feb; 29(2):244-9. PubMed ID: 3717931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-antibiotic use for penetrating abdominal trauma.
    Nelson RM; Benitez PR; Newell MA; Wilson RF
    Arch Surg; 1986 Feb; 121(2):153-6. PubMed ID: 3947216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulbactam/ampicillin versus metronidazole/gentamicin in the treatment of severe pelvic infections.
    Crombleholme W; Landers D; Ohm-Smith M; Robbie MO; Hadley WK; DeKay V; Dahrouge D; Sweet RL
    Drugs; 1986; 31 Suppl 2():11-3. PubMed ID: 3013566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical risk factors for prolonged PT/PTT in abdominal sepsis patients treated with moxalactam or tobramycin plus clindamycin.
    Baxter JG; Marble DA; Whitfield LR; Wels PB; Walczak P; Schentag JJ
    Ann Surg; 1985 Jan; 201(1):96-102. PubMed ID: 3966831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathophysiology and management of postcesarean endomyometritis.
    Duff P
    Obstet Gynecol; 1986 Feb; 67(2):269-76. PubMed ID: 3511414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aztreonam plus clindamycin vs. tobramycin plus clindamycin for the treatment of intraabdominal infections.
    Birolini D; Moraes MF; de Souza OS
    Rev Infect Dis; 1985; 7 Suppl 4():S724-8. PubMed ID: 3909330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized clinical trial of moxalactam alone versus tobramycin plus clindamycin in abdominal sepsis.
    Schentag JJ; Wels PB; Reitberg DP; Walczak P; Van Tyle JH; Lascola RJ
    Ann Surg; 1983 Jul; 198(1):35-41. PubMed ID: 6222710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of neutropenic infection: a randomized trial comparing latamoxef (moxalactam) with cephradine plus tobramycin.
    Bezwoda WR; Derman DP; Perkins S; Cassel R
    J Antimicrob Chemother; 1985 Feb; 15(2):239-45. PubMed ID: 3884566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preservation of colonization resistance parameters during empiric therapy with aztreonam in the febrile neutropenic patient.
    Louie TJ; Chubb H; Bow EJ; Conly JM; Harding GK; Rayner E; James M
    Rev Infect Dis; 1985; 7 Suppl 4():S747-61. PubMed ID: 3909333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized study of moxalactam versus gentamicin and clindamycin in penetrating abdominal trauma.
    Kreis DJ; Augenstein D; Martinez O; Echenique M; Plasencia G; Vopal JJ; Byers P; Gomez GA
    Surg Gynecol Obstet; 1986 Jul; 163(1):1-4. PubMed ID: 3726718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of moxalactam with the combination of clindamycin and an aminoglycoside in the treatment of common surgical infections.
    Rambo WM; Del Bene VE; Burkey LG; Collins CD; Richmond DK
    Rev Infect Dis; 1982; 4 Suppl():S683-7. PubMed ID: 6218583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of ceftazidime versus clindamycin-tobramycin in the treatment of obstetrical and gynecological infections.
    Blanco JD; Gibbs RS; Duff P; Castaneda YS; St Clair PJ
    Antimicrob Agents Chemother; 1983 Oct; 24(4):500-4. PubMed ID: 6360038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective, randomized comparison of the efficacy and safety of netilmicin-clindamycin and tobramycin-clindamycin in the treatment of serious systemic infections.
    Kahalley S; Chandler J; Hawkins J; Norris G; Waugespack R; Snow RM
    Clin Ther; 1985; 7(4):497-506. PubMed ID: 4016829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.